Our CEO, Peter Moesta, recently spoke with Anna Rose Welch from Biosimilar Development regarding Adello's rebranding effort. In the interview, Peter talks about Adello's singular focus on #biosimilars and the importance of building a company culture from the bottom up.
About Adello Biologics, LLC
Adello is a privately held, U.S.-based biotechnology company that leads with science to accelerate development and drive manufacturing efficiency. The company’s aim is to provide high-quality, affordable biosimilars to patients worldwide. Headquartered in Piscataway, NJ and driven by a team of highly skilled industry veterans, Adello is advancing a strategic pipeline of proteins and complex monoclonal antibodies with lead candidates in oncology and immunology. For more information, visit Adellobio.com.
Learn more about biosimilars: adellobio.com/biosimilars
For additional information:
Adello Biologics, LLC
Source: Adello Biologics, LLC